TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
JANX

Janux Therapeutics Inc

Healthcare · Biotechnology

17.50$ +2.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JANX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
96.9% 99.0% 99.3% 91.3% 91.8% 97.4% 96.9%
96.9% 48.2% 9.4% 14.1% 5.0% 40.6% 5.2%
96.9% 48.2% 98.7% 89.8% 90.4% 96.6% 95.9%
0.0% 49.3% 0.1% 0.2% 0.6% 0.5% 0.6%
-0.1% -0.2% -0.6%
3.1% 1.0% 0.4% 1.9%
1,270.0% 190.3% 3.6% 11.9% 9.5% 3.6% 5.0%
681.4% 19.6% 3.4% 4.5% 3.4% 1.6% 2.5%
589.1% 4.6% 0.1% 0.2% 0.4% 0.2% 0.2%
39.3% 2.6% 0.6% 0.6% 0.6% 0.4% 0.5%
-1,170.0% -90.3% 96.4% 88.1% 90.5% 96.4% 95.0%
-1,171.6% -90.9% -12.5% -30.3% -44.4% -22.4% -34.9%
6,128.4% 256.6% 10.9% 11.4% 11.6% 5.1% 6.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?